Cementless Oxford Partial Knee Controlled Observational Study

NCT ID: NCT02350049

Last Updated: 2017-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

391 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-11-30

Study Completion Date

2017-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the safety and effectiveness of the Cementless Oxford Partial Knee System.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is designed to document and compare the clinical and radiographic results of the Cementless Oxford Partial Knee System (investigational device) to those of the cemented Oxford Partial Knee System (control device).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis Avascular Necrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Investigational

Cementless Medial Partial Knee

No interventions assigned to this group

Control

Cemented Medial Partial Knee

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* have primary diagnosis of osteoarthritis or avascular necrosis limited to the medial compartment of the knee
* signed informed consent for patients contributing to investigational or control if required
* Male or female over the age of 21 years at the time of surgery
* Undergone primary partial knee arthroplasty as unilateral arthroplasty or bilateral arthroplasty, simultaneously or otherwise
* Patients that are current residents of the United Kingdom

Exclusion Criteria

* Evidence of infection, sepsis, and osteomyelitis at the time of surgery
* Use in the lateral compartment of the knee
* Rheumatoid arthritis or other forms of inflammatory joint disease
* Revision of a failed prosthesis, failed upper tibial osteotomy or post-traumatic arthritis after tibial plateau fracture
* Insufficiency of the collateral, anterior, or posterior cruciate ligaments which would preclude stability of the device
* Partial or full thickness cartilage disease or damage to central part of the lateral femoral condyle
* Osteoporosis or insufficient bone stock
* Metabolic disorders which may impair bone formation
* Osteomalacia
* Distant foci of infection which may spread to the implant site
* Rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram
* Vascular insufficiency, muscular atrophy, neuromuscular disease
* Incomplete or deficient soft tissue surrounding the knee
* Charcot's disease
* A fixed varus deformity (not passively correctable) of greater than 15 degrees
* A flexion deformity greater than 15 degrees
* Refuse to sign informed consent if it is required
* Patients that are not current residents of the United Kingdom
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Prof. David Murray, BA Hons, BChir, FRCS, MD

Role: PRINCIPAL_INVESTIGATOR

Nuffield Orthopaedic Centre

Prof. Hemant Pandit, MBBS, MS, DNB, FRCS, DPhil

Role: STUDY_DIRECTOR

Nuffield Orthopaedic Centre

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ORTHO.CR.GK10

Identifier Type: -

Identifier Source: org_study_id